Rational antimicrobial therapy for bacterial meningitis in children
10.3760/cma.j.issn.2095-428X.2019.12.004
- VernacularTitle: 儿童细菌性脑膜炎抗生素的规范治疗
- Author:
Liang HUANG
1
,
2
,
3
;
Rong LUO
4
,
5
Author Information
1. Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China
2. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China
3. West China School of Pharmacy, Sichuan University, Chengdu 610041, China
4. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China
5. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China
- Publication Type:Journal Article
- Keywords:
Child;
Bacterial meningitis;
Antimicrobial
- From:
Chinese Journal of Applied Clinical Pediatrics
2019;34(12):898-902
- CountryChina
- Language:Chinese
-
Abstract:
Bacterial meningitis is a common infectious disease of central nervous system in children.Timely, effective, adequate, and sufficient course of antibiotics therapy is the key to reduce mortality rate and incidence of sequelae, and improve prognosis.Starting reasonable empirical antimicrobial therapy according to the onset ages, clinical situation, and drug resistance status, and obtaining the evidence of pathogens timely to start effectively target treatment, optimizing the therapeutic scheme based on pharmacokinetic/pharmacodynamic theory, strengthening pharmaceutical care, play vital roles in effectively controlling infection and eliminating pathogens, improving prognosis and reducing bacterial drug resistance.